BLMH antibody
-
- Target See all BLMH Antibodies
- BLMH (Bleomycin Hydrolase (BLMH))
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BLMH antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Cross-Reactivity
- Human
- Characteristics
-
Rabbit Polyclonal antibody to BLMH (bleomycin hydrolase)
BLMH antibody [N1C1] - Purification
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human BLMH. The exact sequence is proprietary.
- Isotype
- IgG
- Top Product
- Discover our top product BLMH Primary Antibody
-
-
- Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Comment
-
Positive Control: A549
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.87 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
- Preservative
- Thimerosal (Merthiolate)
- Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- BLMH (Bleomycin Hydrolase (BLMH))
- Alternative Name
- bleomycin hydrolase (BLMH Products)
- Background
-
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution, however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily.
Cellular Localization: Cytoplasm - Molecular Weight
- 53 kDa
- Gene ID
- 642
- UniProt
- Q13867
-